Featuring
perspectives from Dr Aditya Bardia, Dr Harold J Burstein, Prof
Giuseppe Curigliano, Dr Sara A Hurvitz, Dr Hope S Rugo and Dr Joyce
O’Shaughnessy, moderated by Dr Rugo, including the following
topics:
Introduction (0:00)
Optimizing the Management of HER2-Positive
Metastatic Breast Cancer (mBC) — Dr Hurvitz (4:38)
Individualized Selection of Up-Front Therapy
for Patients with HR-Positive, HER2-Negative mBC — Dr Burstein
(30:11)
Selection and Sequencing of Treatment for
Patients with HR-Positive, HER2-Negative mBC Who Experience Disease
Progression on CDK4/6 Inhibition — Dr Rugo (48:15)
Current and Future Role of HER2-Targeted
Therapy for HER2-Low and HER2-Ultralow Disease — Prof Curigliano
(1:07:24)
Selection and Sequencing of Therapy for
Patients with Metastatic Triple-Negative Breast Cancer — Dr
O’Shaughnessy (1:22:11)
Current and Future Strategies for the Care of
Individuals with Endocrine-Refractory HR-Positive mBC — Dr Bardia
(1:42:24)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.